Drug intelligence / Profile preview

lithocholic acid

Development stage
Unknown
Modality
Small Molecules
Administration
Intraperitoneal, Oral, Dietary
01

Overview

Lithocholic acid is a **secondary bile acid** formed by bacterial action in the colon, specifically through reduction of the hydroxyl group at the 7-position of chenodeoxycholic acid. It acts primarily as a **detergent to solubilize fats for absorption** in the intestine[1][2][3]. While lithocholic acid is considered **toxic to hepatocytes at high concentrations** and has been implicated as a **carcinogen** (due to its ability to induce oxidative stress, DNA damage, and promote tumorigenesis), recent studies also suggest potential beneficial effects. These include **anti-inflammatory actions** in the colon, **activation of the TGR5 receptor**, and selective cytotoxicity against various malignancies[1][2][3][4]. LCA is also an **agonist of the vitamin D receptor**, binds NAPE-PLD to influence lipid signaling, and has shown **anti-aging effects in preclinical models**[1]. It is not currently an approved pharmaceutical but is the focus of ongoing preclinical and mechanistic research.

Other names
3α-hydroxy-5β-cholan-24-oic acid
02

Targets

NAPE-PLD (N-acyl phosphatidylethanolamine-specific phospholipase D)GPBAR1VDR (Vitamin D receptor)

Beyond the preview

Go deeper on lithocholic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lithocholic acid.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call